Effects of parecoxib on analgesia benefit and blood loss following open prostatectomy: a multicentre randomized trial

BMC Anesthesiology
D DirkmannM Eikermann

Abstract

This multi-centre, prospective, randomized, double-blind, placebo-controlled study was designed to test the hypotheses that parecoxib improves patients' postoperative analgesia without increasing surgical blood loss following radical open prostatectomy. 105 patients (64 ± 7 years old) were randomized to receive either parecoxib or placebo with concurrent morphine patient controlled analgesia. Cumulative opioid consumption (primary objective) and the overall benefit of analgesia score (OBAS), the modified brief pain inventory short form (m-BPI-sf), the opioid-related symptom distress scale (OR-SDS), and perioperative blood loss (secondary objectives) were assessed. In each group 48 patients received the study medication for 48 hours postoperatively. Parecoxib significantly reduced cumulative opioid consumption by 24% (43 ± 24.1 mg versus 57 ± 28 mg, mean ± SD, p=0.02), translating into improved benefit of analgesia (OBAS: 2(0/4) versus 3(1/5.25), p=0.01), pain severity (m-BPI-sf: 1(1/2) versus 2(2/3), p < 0.01) and pain interference (m-BPI-sf: 1(0/1) versus 1(1/3), p=0.001), as well as reduced opioid-related side effects (OR-SDS score: 0.3(0.075/0.51) versus 0.4(0.2/0.83), p=0.03). Blood loss was significantly higher at 24 hours...Continue Reading

References

Jan 24, 1998·British Journal of Urology·J D NielsenJ Jespersen
Jul 25, 2000·JAMA : the Journal of the American Medical Association·D M Phillips
Sep 5, 2002·Journal of Clinical Anesthesia·Beverly K PhilipSteven P Burch
Jun 7, 2003·Pain·Sean R MorrisonAlbert L Siu
Jun 28, 2003·The Journal of Thoracic and Cardiovascular Surgery·Elisabeth OttUNKNOWN Ischemia Research and Education Foundation (IREF) Investigators
Nov 19, 2003·The Journal of Pain : Official Journal of the American Pain Society·Michelle WheelerArthur G Lipman
Jul 28, 2004·Pain·Mark P JensenCharles S Cleeland
Aug 31, 2004·Anesthesia and Analgesia·Jeffrey L ApfelbaumConnie Chen
Feb 17, 2005·The New England Journal of Medicine·Robert S BresalierUNKNOWN Adenomatous Polyp Prevention on Vioxx (APPROVe) Trial Investigators
Feb 17, 2005·The New England Journal of Medicine·Scott D SolomonUNKNOWN Adenoma Prevention with Celecoxib (APC) Study Investigators
Feb 17, 2005·The New England Journal of Medicine·Nancy A NussmeierKenneth M Verburg
May 16, 2006·British Journal of Anaesthesia·E MunsterhjelmP H Rosenberg
Nov 6, 2007·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Gisela ScharbertSibylle Kozek-Langenecker
Dec 15, 2007·British Journal of Anaesthesia·G RiestM Eikermann
Apr 18, 2008·Pain·Dominique FletcherUNKNOWN Pain and Regional Anesthesia Committee of the French Anesthesia and Intensive Care Society (SFAR)
Apr 18, 2009·Anesthesia and Analgesia·Paul F WhiteSpencer Liu
Nov 26, 2009·Anesthesiology·Emmanuel MarretMartin R Tramèr
Oct 20, 2010·Hernia : the Journal of Hernias and Abdominal Wall Surgery·A V KyriakidisI Mpesikos
Jun 1, 2011·British Journal of Anaesthesia·I Power
Jul 22, 2014·BJU International·Alexander LairdUNKNOWN British Association of Urological Surgeons (BAUS)

❮ Previous
Next ❯

Citations

Aug 30, 2016·Seminars in Arthritis and Rheumatism·Choochai TeerawattananonWanruchada Katchamart
Feb 10, 2016·Journal of Critical Care·Stefan J SchallerManfred Blobner
Nov 5, 2015·BMC Anesthesiology·Grish P JoshiUNKNOWN PROSPECT collaboration
Jul 28, 2016·Terapevticheskiĭ arkhiv·O K LevchenkoG M Galstyan
Jul 2, 2021·Anaesthesia Critical Care & Pain Medicine·Adrien LemoineUNKNOWN PROSPECT Working Group Of The European Society Of Regional Anaesthesia And Pain Therapy (ESRA)

❮ Previous
Next ❯

Methods Mentioned

BETA
coronary artery bypass
sedation

Clinical Trials Mentioned

NCT00346268

Software Mentioned

Prism
OR
SDS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.